Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Lupus can cause hair loss and nail changes, with treatments available for both.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

A dog in Colorado was diagnosed with leishmaniasis, suggesting the disease might be present in the state.

Boxer dogs may have a genetic skin condition that worsens seasonally and can be treated with certain medications.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A thorough skin history and examination are essential for diagnosing and treating skin conditions effectively.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The document concludes that various hypersensitivity diseases in horses can be diagnosed and treated with methods like immunotherapy and medication, and early aggressive treatment is crucial for severe diseases like equine cutaneous pythiosis.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

A rare skin condition linked to leukemia improved with chemotherapy.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."